What does EUROPHARMA GROUP do?

EUROPHARMA GROUP is a wholesaler in Tongeren-Borgloon. Private Limited, started on 16 April 2009, 1 establishment.

What is the address of EUROPHARMA GROUP?

The registered office of EUROPHARMA GROUP is located at Heersterveldweg 16A box 9, 3700 Tongeren-Borgloon.

Is EUROPHARMA GROUP still active?

Yes. According to the CBE (30 October 2026) EUROPHARMA GROUP is active, legal situation “Normale toestand”, started on 16 April 2009.

Is EUROPHARMA GROUP registered on Peppol?

Yes, EUROPHARMA GROUP is registered on the Peppol network with ID 0208:0811185660.

What is the enterprise number of EUROPHARMA GROUP?

The enterprise number of EUROPHARMA GROUP is BE0811185660.

When was EUROPHARMA GROUP founded?

EUROPHARMA GROUP was founded on 16 April 2009.

Who are the directors of EUROPHARMA GROUP?

According to the 2025 annual accounts, the directors of EUROPHARMA GROUP are: Sebastiano DULIEU.

Is EUROPHARMA GROUP a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 16 April 2009; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did EUROPHARMA GROUP make in 2025?

EUROPHARMA GROUP posted a profit after taxes of € 127,061 in financial year 2025.

What is the revenue of EUROPHARMA GROUP?

As a small company, EUROPHARMA GROUP is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 369,887.

Does EUROPHARMA GROUP have a website?

Yes, EUROPHARMA GROUP has a website at europharmagroup.com.

EUROPHARMA GROUP (Private Limited) - Tongeren-Borgloon

Dossier EUROPHARMA GROUP, printed on 30 October 2026 from databakkes.be/en/0811185660/europharma-group. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

EUROPHARMA GROUP from Tongeren-Borgloon, company number BE0811185660, closed financial year 2025 with a result of € 127,061 after tax. For that financial year EUROPHARMA GROUP recorded a gross margin of € 369,887 and equity of € 453,758. Compared with financial year 2024, the result moved from € 72,635 to € 127,061. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 22, 2026.

What it is worth Growing

€ 453,758

▲ 39% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 127,061

▲ 75% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 67,841

▲ € 56,598 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 443,758.

People and assets in 2025

Wage cost

€ 124,764

▲ 31% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 26,484

▼ 42% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 157,356

▼ 29% vs 2024

€ 55,108 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 250,181

▲ 37% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 82,469

▲ 11% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 281,172 Gross margin 2022: € 281,172 First fiscal year in the series	€ 283,498 Gross margin 2023: € 283,498 ▲ 1% vs 2022 (€ 281,172) Favourable step	€ 277,446 Gross margin 2024: € 277,446 ▼ 2% vs 2023 (€ 283,498) Unfavourable step	€ 369,887 Gross margin 2025: € 369,887 ▲ 33% vs 2024 (€ 277,446) Favourable step	▲ 33%
Profit after taxes	€ 101,709 Profit after taxes 2022: € 101,709 First fiscal year in the series	€ 69,783 Profit after taxes 2023: € 69,783 ▼ 31% vs 2022 (€ 101,709) Unfavourable step	€ 72,635 Profit after taxes 2024: € 72,635 ▲ 4% vs 2023 (€ 69,783) Favourable step	€ 127,061 Profit after taxes 2025: € 127,061 ▲ 75% vs 2024 (€ 72,635) Favourable step	▲ 75%
Equity	€ 234,280 Equity 2022: € 234,280 First fiscal year in the series	€ 254,062 Equity 2023: € 254,062 ▲ 8% vs 2022 (€ 234,280) Favourable step	€ 326,697 Equity 2024: € 326,697 ▲ 29% vs 2023 (€ 254,062) Favourable step	€ 453,758 Equity 2025: € 453,758 ▲ 39% vs 2024 (€ 326,697) Favourable step	▲ 39%
Total debts	€ 436,370 Total debts 2022: € 436,370 First fiscal year in the series	€ 504,183 Total debts 2023: € 504,183 ▲ 16% vs 2022 (€ 436,370) Unfavourable step	€ 480,059 Total debts 2024: € 480,059 ▼ 5% vs 2023 (€ 504,183) Favourable step	€ 491,081 Total debts 2025: € 491,081 ▲ 2% vs 2024 (€ 480,059) Unfavourable step	▲ 2%
Cash	€ 25,316 Cash 2022: € 25,316 First fiscal year in the series	€ 2,243 Cash 2023: € 2,243 ▼ 91% vs 2022 (€ 25,316) Unfavourable step	€ 11,243 Cash 2024: € 11,243 ▲ € 9,000 vs 2023 (€ 2,243) Favourable step	€ 67,841 Cash 2025: € 67,841 ▲ € 56,598 vs 2024 (€ 11,243) Favourable step	▲ € 56,598
Land & buildings	€ 201,126 Land & buildings 2022: € 201,126 First fiscal year in the series	€ 176,775 Land & buildings 2023: € 176,775 ▼ 12% vs 2022 (€ 201,126) Unchanged	€ 152,425 Land & buildings 2024: € 152,425 ▼ 14% vs 2023 (€ 176,775) Unchanged	€ 128,074 Land & buildings 2025: € 128,074 ▼ 16% vs 2024 (€ 152,425) Unchanged	▼ 16%
Retained profit	€ 224,280 Retained profit 2022: € 224,280 First fiscal year in the series	€ 244,062 Retained profit 2023: € 244,062 ▲ 9% vs 2022 (€ 224,280) Favourable step	€ 316,697 Retained profit 2024: € 316,697 ▲ 30% vs 2023 (€ 244,062) Favourable step	€ 443,758 Retained profit 2025: € 443,758 ▲ 40% vs 2024 (€ 316,697) Favourable step	▲ 40%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 50,000 Dividend 2023: € 50,000 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 50,000) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 237,045 Bank debt 2022: € 237,045 First fiscal year in the series	€ 249,139 Bank debt 2023: € 249,139 ▲ 5% vs 2022 (€ 237,045) Unfavourable step	€ 222,458 Bank debt 2024: € 222,458 ▼ 11% vs 2023 (€ 249,139) Favourable step	€ 157,356 Bank debt 2025: € 157,356 ▼ 29% vs 2024 (€ 222,458) Favourable step	▼ 29%
Balance sheet total	€ 670,650 Balance sheet total 2022: € 670,650 First fiscal year in the series	€ 758,245 Balance sheet total 2023: € 758,245 ▲ 13% vs 2022 (€ 670,650) Unchanged	€ 806,756 Balance sheet total 2024: € 806,756 ▲ 6% vs 2023 (€ 758,245) Unchanged	€ 944,839 Balance sheet total 2025: € 944,839 ▲ 17% vs 2024 (€ 806,756) Unchanged	▲ 17%

Key figures of EUROPHARMA GROUP, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to EUROPHARMA GROUP?

What happened at EUROPHARMA GROUP in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 22, 2026 New annual accounts for financial year 2025: profit of € 127,061 (▲ 75% vs 2024). filed late Source: NBB ↗
Apr 17, 2009 New establishment in Tongeren-Borgloon. KBO
Apr 16, 2009 Start of the company according to the CBE. KBO

In short

From € 101,709 profit in 2022 to € 127,061 profit in 2025.

Paid € 176,491 in corporate taxes since 2022.

Best year ever: 2025, with € 127,061 profit.

Paid out € 50,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Sebastiano DULIEU

EUROPHARMA GROUP

IMPERO VINI

Behind EUROPHARMA GROUP is Sebastiano DULIEU. Sebastiano DULIEU is also behind IMPERO VINI.

Directors

According to the 2025 annual accounts

Sebastiano DULIEU

Director

Also active at: IMPERO VINI

Establishments

Establishment units

Physical locations of this company

Registered office

Heersterveldweg 16A box 9

3700 Tongeren-Borgloon

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 9 companies are registered at this address.

All companies at this address →

JK Technieken

€ 101,340 gross margin · 2024

JPConcept

€ -52 gross margin · 2025

DIGITONG

€ 745,380 gross margin · 2025

AQUA-SAVING

GLOBAL UNITY

€ -24,713 gross margin · 2025

+4 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTP europharmagroup.com

Technologies

Google AnalyticsGoogle MapsPHPjQuery

Hosting & Email

Email provider

Self-hosted

Hosting

OVH, FR

Domain

europharmagroup.com

Registered

2009-03-25

Registrar

EuroDNS S.A.

Expires

2027-03-25

Website info

HTTPS Nee

Languages FR

Features

Contact page

Security

✗ HTTPS

✓ SPF

✓ DMARC

Details

Company number

0811.185.660

VAT number

BE 0811.185.660

Registered office

Heersterveldweg 16A bus 9, 3700 Tongeren-Borgloon

Names & denominations

EUROPHARMA GROUP

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

16 April 2009

Peppol

Active · Active since 19 Dec 2025

Contact

europharmagroup.com

Activities · NACE

Groothandel in parfumerieën en cosmetica

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

View on CBE Public ↗ Annual accounts (NBB) ↗

EUROPHARMA GROUP

Financials

What happened to EUROPHARMA GROUP?

Management

Directors

Establishments

Establishment units

Who else lives here?

Website

Technologies

Hosting & Email

Domain

Website info

Features

Security

Details

Frequently asked questions